Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 12(1): 12190, 2022 07 16.
Article in English | MEDLINE | ID: mdl-35842487

ABSTRACT

We have previously established a novel mouse model of lung fibrosis based on Adeno-associated virus (AAV)-mediated pulmonary overexpression of TGFß1. Here, we provide an in-depth characterization of phenotypic and transcriptomic changes (mRNA and miRNA) in a head-to-head comparison with Bleomycin-induced lung injury over a 4-week disease course. The analyses delineate the temporal state of model-specific and commonly altered pathways, thereby providing detailed insights into the processes underlying disease development. They further guide appropriate model selection as well as interventional study design. Overall, Bleomycin-induced fibrosis resembles a biphasic process of acute inflammation and subsequent transition into fibrosis (with partial resolution), whereas the TGFß1-driven model is characterized by pronounced and persistent fibrosis with concomitant inflammation and an equally complex disease phenotype as observed upon Bleomycin instillation. Finally, based on an integrative approach combining lung function data, mRNA/miRNA profiles, their correlation and miRNA target predictions, we identify putative drug targets and miRNAs to be explored as therapeutic candidates for fibrotic diseases. Taken together, we provide a comprehensive analysis and rich data resource based on RNA-sequencing, along with a strategy for transcriptome-phenotype coupling. The results will be of value for TGFß research, drug discovery and biomarker identification in progressive fibrosing interstitial lung diseases.


Subject(s)
MicroRNAs , Pulmonary Fibrosis , Animals , Bleomycin/adverse effects , Bleomycin/metabolism , Dependovirus/genetics , Disease Models, Animal , Fibrosis , Gene Expression Profiling , Inflammation/pathology , Lung/pathology , Mice , MicroRNAs/metabolism , Phenotype , Pulmonary Fibrosis/chemically induced , Pulmonary Fibrosis/genetics , Pulmonary Fibrosis/metabolism , RNA, Messenger/metabolism
2.
Adipocyte ; 7(4): 277-284, 2018.
Article in English | MEDLINE | ID: mdl-30161013

ABSTRACT

Despite increased knowledge of nutrient intake regulation and energy homeostasis, treatment options for obesity remain limited. Food reward consists of two branches: gustatory and post-ingestive nutritive information. Drosophila lacking dSLC5A11 (sodium/glucose cotransporter 6-SGLT6) prefer L-glucose over D-glucose independently of their state of satiety. Human SGLT6 is an active transporter of myo-inositol and D-glucose. We investigated expression of SGLT6 in human tissue and found a significant expression in the small intestine and brain. The preference between a metabolizable and a non-metabolizable sugar was tested in 3 mouse models with a selective and potent SGLT6 inhibitor. No influence on sugar preference was seen with SGLT6 inhibition. These studies suggest that SGLT6 does not play a significant role in nutrient sensing in mammals.


Subject(s)
Anti-Obesity Agents/pharmacology , Heat-Shock Proteins/antagonists & inhibitors , Heat-Shock Proteins/metabolism , Obesity/drug therapy , Obesity/metabolism , Symporters/antagonists & inhibitors , Symporters/metabolism , Animals , Anti-Obesity Agents/pharmacokinetics , Anti-Obesity Agents/therapeutic use , Caco-2 Cells , Food Preferences/drug effects , Glucose/metabolism , HEK293 Cells , Humans , Inositol/metabolism , Male , Mice , Mice, Inbred C57BL , Molecular Targeted Therapy
3.
Sci Rep ; 7(1): 149, 2017 03 10.
Article in English | MEDLINE | ID: mdl-28273952

ABSTRACT

Extracellular matrix (ECM) composition and stiffness are major driving forces for the development and persistence of fibrotic diseases. Lysyl oxidase (LOX) and LOX-like (LOXL) proteins play crucial roles in ECM remodeling due to their collagen crosslinking and intracellular functions. Here, we systematically investigated LOX/L expression in primary fibroblasts and epithelial cells under fibrotic conditions, Bleomycin (BLM) induced lung fibrosis and in human IPF tissue. Basal expression of all LOX/L family members was detected in epithelial cells and at higher levels in fibroblasts. Various pro-fibrotic stimuli broadly induced LOX/L expression in fibroblasts, whereas specific induction of LOXL2 and partially LOX was observed in epithelial cells. Immunohistochemical analysis of lung tissue from 14 IPF patients and healthy donors revealed strong induction of LOX and LOXL2 in bronchial and alveolar epithelium as well as fibroblastic foci. Using siRNA experiments we observed that LOXL2 and LOXL3 were crucial for fibroblast-to-myofibroblast transition (FMT). As FMT could only be reconstituted with an enzymatically active LOXL2 variant, we conclude that LOXL2 enzymatic function is crucial for fibroblast transdifferentiation. In summary, our study provides a comprehensive analysis of the LOX/L family in fibrotic lung disease and indicates prominent roles for LOXL2/3 in fibroblast activation and LOX/LOXL2 in IPF.


Subject(s)
Amino Acid Oxidoreductases/metabolism , Bleomycin/adverse effects , Protein-Lysine 6-Oxidase/metabolism , Pulmonary Fibrosis/enzymology , Animals , Cell Line , Cell Transdifferentiation , Fibroblasts/cytology , Fibroblasts/metabolism , Humans , Male , Mice , Multigene Family , Myofibroblasts/cytology , Myofibroblasts/metabolism , Pulmonary Fibrosis/chemically induced
4.
Am J Respir Cell Mol Biol ; 53(3): 291-302, 2015 Sep.
Article in English | MEDLINE | ID: mdl-25845025

ABSTRACT

Viral vectors have been applied successfully to generate disease-related animal models and to functionally characterize target genes in vivo. However, broader application is still limited by complex vector production, biosafety requirements, and vector-mediated immunogenic responses, possibly interfering with disease-relevant pathways. Here, we describe adeno-associated virus (AAV) variant 6.2 as an ideal vector for lung delivery in mice, overcoming most of the aforementioned limitations. In a proof-of-concept study using AAV6.2 vectors expressing IL-13 and transforming growth factor-ß1 (TGF-ß1), we were able to induce hallmarks of severe asthma and pulmonary fibrosis, respectively. Phenotypic characterization and deep sequencing analysis of the AAV-IL-13 asthma model revealed a characteristic disease signature. Furthermore, suitability of the model for compound testing was also demonstrated by pharmacological intervention studies using an anti-IL-13 antibody and dexamethasone. Similarly, the AAV-TGF-ß1 fibrosis model showed several disease-like pathophenotypes monitored by micro-computed tomography imaging and lung function measurement. Most importantly, analyses using stuffer control vectors demonstrated that in contrast to a common adenovirus-5 vector, AAV6.2 vectors did not induce any measurable inflammation and therefore carry a lower risk of altering relevant readouts. In conclusion, we propose AAV6.2 as an ideal vector system for the functional characterization of target genes in the context of pulmonary diseases in mice.


Subject(s)
Asthma/immunology , Dependovirus/genetics , Idiopathic Pulmonary Fibrosis/immunology , Animals , Asthma/genetics , Asthma/metabolism , Disease Models, Animal , Female , Genetic Vectors , Idiopathic Pulmonary Fibrosis/genetics , Idiopathic Pulmonary Fibrosis/metabolism , Interleukin-13/biosynthesis , Interleukin-13/genetics , Mice, Inbred BALB C , Transduction, Genetic , Transforming Growth Factor beta1/biosynthesis , Transforming Growth Factor beta1/genetics
5.
Eur J Immunol ; 41(11): 3208-18, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21830208

ABSTRACT

The spleen tyrosine kinase (Syk) is a key mediator of immunoreceptor signaling in immune cells. Thus, interfering with the function of Syk by genetic deletion or pharmacological inhibition might influence a variety of allergic and autoimmune processes. Since conventional Syk knockout mice are not viable, studies addressing the effect of Syk deletion in adult animals have been limited. To further explore functions of Syk in animal models of allergy and to shed light on the role of Syk in the in vivo migration of neutrophils and monocytes, we generated inducible Syk knockout mice. These mice harbor a floxed Syk gene and a tamoxifen-inducible Cre recombinase under the control of the ubiquitously active Rosa26-promoter. Thus, treatment of mice with tamoxifen leads to the deletion of Syk in all organs. Syk-deleted mice were analyzed in mast cell-dependent models and in models focusing on neutrophil and monocyte migration. We show that Syk deletion in adult mice reduces inflammatory responses in mast cell-driven animal models of allergy and asthma but has no effect on the migration of neutrophils and monocytes. Therefore, the inducible Syk knockout mice presented here provide a valuable tool to further explore the role of Syk in disease-related animal models.


Subject(s)
Cell Movement , Chemotaxis, Leukocyte/immunology , Hypersensitivity/immunology , Intracellular Signaling Peptides and Proteins/immunology , Monocytes/immunology , Neutrophils/immunology , Protein-Tyrosine Kinases/immunology , Animals , Cell Differentiation/immunology , Cell Separation , Flow Cytometry , Inflammation/immunology , Male , Mast Cells/cytology , Mast Cells/immunology , Mice , Mice, Inbred C57BL , Mice, Knockout , Monocytes/cytology , Neutrophils/cytology , Signal Transduction/immunology , Syk Kinase
SELECTION OF CITATIONS
SEARCH DETAIL
...